T. Rowe Price Associates’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-901
Closed -$19K 2971
2023
Q4
$19K Buy
901
+112
+14% +$2.36K ﹤0.01% 2874
2023
Q3
$26K Sell
789
-727
-48% -$24K ﹤0.01% 2834
2023
Q2
$51K Buy
1,516
+789
+109% +$26.5K ﹤0.01% 2796
2023
Q1
$31K Hold
727
﹤0.01% 2828
2022
Q4
$25K Hold
727
﹤0.01% 2867
2022
Q3
$36K Hold
727
﹤0.01% 2867
2022
Q2
$29K Buy
727
+149
+26% +$5.94K ﹤0.01% 2904
2022
Q1
$21K Buy
578
+113
+24% +$4.11K ﹤0.01% 2948
2021
Q4
$45K Sell
465
-47
-9% -$4.55K ﹤0.01% 2926
2021
Q3
$64K Buy
512
+25
+5% +$3.13K ﹤0.01% 2887
2021
Q2
$61K Buy
+487
New +$61K ﹤0.01% 2881
2020
Q1
Sell
-2,713
Closed -$194K 2551
2019
Q4
$194K Sell
2,713
-762
-22% -$54.5K ﹤0.01% 2403
2019
Q3
$182K Sell
3,475
-2,721
-44% -$143K ﹤0.01% 2389
2019
Q2
$333K Sell
6,196
-27
-0.4% -$1.45K ﹤0.01% 2265
2019
Q1
$442K Sell
6,223
-1,773
-22% -$126K ﹤0.01% 2159
2018
Q4
$638K Buy
7,996
+30
+0.4% +$2.39K ﹤0.01% 1983
2018
Q3
$3.72M Buy
7,966
+11
+0.1% +$5.13K ﹤0.01% 1489
2018
Q2
$3.16M Buy
7,955
+7
+0.1% +$2.78K ﹤0.01% 1498
2018
Q1
$2.43M Buy
7,948
+1
+0% +$306 ﹤0.01% 1526
2017
Q4
$2.34M Buy
7,947
+3
+0% +$883 ﹤0.01% 1529
2017
Q3
$4.35M Hold
7,944
﹤0.01% 1441
2017
Q2
$4.73M Buy
7,944
+2,864
+56% +$1.71M ﹤0.01% 1419
2017
Q1
$2.18M Sell
5,080
-3,200
-39% -$1.37M ﹤0.01% 1558
2016
Q4
$4.26M Buy
+8,280
New +$4.26M ﹤0.01% 1436